Paparella Domenico, Cappabianca Giangiuseppe, Malvindi Piergiorgio, Paramythiotis Andreas, Galeone Antonella, Veneziani Nicola, Fondacone Corrado, de Luca Tupputi Schinosa Luigi
Division of Cardiac Surgery, Department of Emergency and Organ Transplant, University of Bari, Italy.
Eur J Cardiothorac Surg. 2007 Sep;32(3):481-7. doi: 10.1016/j.ejcts.2007.06.015. Epub 2007 Jul 23.
Perioperative myocardial ischemia is less pronounced in off-pump coronary artery bypass (OPCAB) compared to on-pump coronary artery bypass; however, the threshold over which the postoperative release of cardiac troponin I (cTnI) release and creatine kinase-MB (CK-MB) after OPCAB should be considered clinically relevant is unknown. The study was designated to evaluate if perioperative myocardial damage, measured by means of postoperative release of cTnI and CK-MB, has an influence on short- and mid-term outcome after OPCAB operations.
Two hundred and sixty-one unselected patients undergoing OPCAB had cTnI and CK-MB measured preoperatively and nine times postoperatively. Postoperative peak values were evaluated and the 80th percentiles were used to segregate the population into two groups for each marker. The following cut-offs were used: 7.1 ng/dl for cTnI peak and 36.3 ng/dl for CK-MB peak.
Patients with cTnI>7.1 ng/ml (n=51) and CK-MB>36.3 ng/ml (n=48) had a longer mechanical ventilation and ICU length of stay. Nevertheless, hospital mortality did not differ between groups. Survival after 3 years was 92.8+/-2.3% and 81.8+/-6.2 for patients with postoperative cTnI peak<or=7.1 ng/ml and >7.1 ng/ml, respectively (p=0.003). It was 93+/-2.2% and 80+/-6.8% for patients with CK-MB<or=36.3 ng/ml and >36.3 ng/ml, respectively (p=0.005). Adjusted hazard ratios for mid-term mortality were HR 2.7 (CI 1-7.6), p=0.05 for cTnI>7.1 ng/dl and HR 3.1 (CI 1-9.1), p=0.04 for CK-MB>36.3 ng/ml.
Perioperative myocardial damage should not be considered an innocuous event following OPCAB operations since the survival rate over 3 years is significantly worse in patients with the highest postoperative peak release of cTnI and CK-MB.
与体外循环冠状动脉搭桥术相比,非体外循环冠状动脉搭桥术(OPCAB)围手术期心肌缺血症状较轻;然而,OPCAB术后心肌肌钙蛋白I(cTnI)释放及肌酸激酶同工酶(CK-MB)超过何种阈值应被视为具有临床意义尚不清楚。本研究旨在评估通过术后cTnI及CK-MB释放来衡量的围手术期心肌损伤是否会对OPCAB术后的短期及中期预后产生影响。
261例接受OPCAB的未经过筛选的患者在术前及术后9次测量了cTnI及CK-MB。评估术后峰值,并将第80百分位数用于将人群按照每个标志物分为两组。采用以下临界值:cTnI峰值为7.1 ng/dl,CK-MB峰值为36.3 ng/dl。
cTnI>7.1 ng/ml(n=51)及CK-MB>36.3 ng/ml(n=48)的患者机械通气时间及重症监护病房(ICU)住院时间更长。然而,两组间的医院死亡率并无差异。术后cTnI峰值≤7.1 ng/ml及>7.1 ng/ml的患者3年生存率分别为92.8±2.3%及81.8±6.2%(p=0.003)。CK-MB≤36.3 ng/ml及>36.3 ng/ml的患者3年生存率分别为93±2.2%及80±6.8%(p=0.005)。中期死亡率的校正风险比为:cTnI>7.1 ng/dl时,HR 2.7(CI 1-7.6),p=0.05;CK-MB>36.3 ng/ml时,HR 3.1(CI 1-9.1),p=0.04。
OPCAB术后围手术期心肌损伤不应被视为无害事件,因为术后cTnI及CK-MB峰值释放最高的患者3年生存率明显更低。